Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 18, 2022
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
Tue, May 17, 2022
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
Gil Blum Maintained (TSHA) at Strong Buy with Decreased Target to $20 on, May 17th, 2022
Gil Blum of Needham, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $32 to $20 on, May 17th, 2022.
Gil has made no other calls on TSHA in the last 4 months.
There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Gil
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $35 on, Friday, April 1st, 2022
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $27 on, Friday, April 1st, 2022
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $36 on, Friday, April 1st, 2022
- Jack Allen of "Baird" Initiated at Buy and Held Target at $26 on, Wednesday, March 9th, 2022
- Yanan Zhu of "Wells Fargo" Initiated at Buy and Held Target at $25 on, Tuesday, March 1st, 2022
